| Catalog No | Product Description | CAS No. | Purity | Structural Formula |
|---|---|---|---|---|
| BP0032 |
1-Monomyristin
1-Monomyristin is a 1-monoglyceride with tetradecanoyl (myristoyl) as the acyl group. It has a role as a Caenorhabditis elegans metabolite. It is a 1-monoglyceride and a tetradecanoate ester.
1-Monomyristin was extracted from Serenoa repens and inhibited the hydrolysis of 2-oleoyl glycerol (IC50=32 μ M) and the activity of fatty acid amide hydrolase (FAAH) (IC50=18 μ M). 1-Monomyristin has antibacterial activity against Staphylococcus aureus and actinomycetes, as well as antifungal activity against Candida albicans.
|
589-68-4 | 98% |
|
| BP0034 |
1-Octacosanol
1-Octacosanol is an ultra-long-chain primary fatty alcohol that is octacosane in which a hydrogen attached to one of the terminal carbons is replaced by a hydroxy group. It has a role as a plant metabolite. It is an ultra-long-chain primary fatty alcohol and a fatty alcohol 28:0. It derives from a hydride of an octacosane.
1-Octacosanol is reported to possess cholesterol-lowering effects, antiaggregatory properties, cytoprotective use, and ergogenic properties, it is used as a nutritional supplement.
1-Octacosanol is a straight chain aliphatic 28 carbon fatty alcohol and the main component of cholesterol lowering agent docosanol. 1-Octacosanol has various activities such as anti fatigue, anti angiogenesis, cholesterol lowering, and insecticidal.
|
557-61-9 | 95%GC |
|
| BP3525 |
L-Methionine
L-methionine is the L-enantiomer of methionine. It has a role as a micronutrient, a nutraceutical, an antidote to paracetamol poisoning, a mouse metabolite and a human metabolite. It is a L-alpha-amino acid, a methionine, an aspartate family amino acid and a proteinogenic amino acid. It is a conjugate base of a L-methioninium. It is a conjugate acid of a L-methioninate. It is an enantiomer of a D-methionine. It is a tautomer of a L-methionine zwitterion. L-Methionine is marker of cell viability and estimating proliferative activity. L-Methionine and L-cystine can improve hyperlipidemia by restoring LPL and HSL activities, it also might be a new potential drug for Parkinson's disease treatment.
|
63-68-3 | 98% |
|
Shenshuai
Wenjing
Hedandan